Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Lowes

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
American Heart Journal|October 31, 2007
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trialArthur M Feldman, Ron M Oren, William T Abraham, et al.
The New England Journal of Medicine|March 19, 2019
A Fully Magnetically Levitated Left Ventricular Assist Device - Final ReportMandeep R Mehra, Nir Uriel, Yoshifumi Naka, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
American Heart Journal|October 31, 2007
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trialArthur M Feldman, Ron M Oren, William T Abraham, et al.
The New England Journal of Medicine|March 19, 2019
A Fully Magnetically Levitated Left Ventricular Assist Device - Final ReportMandeep R Mehra, Nir Uriel, Yoshifumi Naka, et al.
Pageof 7